James Briscoe Explained

James Briscoe
Fields:Developmental biology
Workplaces:Francis Crick Institute
Columbia University
National Institute for Medical Research
Alma Mater:University of Warwick (BSc)
King's College London (PhD)
Thesis Title:JAKs, STATs and signal transduction in response to the interferons and interleukin-6
Thesis Url:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336443
Thesis Year:1996
Doctoral Advisor:Ian M. Kerr
Awards:EMBO Gold Medal (2008)
EMBO Member (2009)
Spouses:)-->
Partners:)-->

James Briscoe [1] is a senior group leader at the Francis Crick Institute in London[2] [3] and editor-in-chief of the journal Development.[3]

Education

Briscoe was educated at the University of Warwick and King's College London where he was awarded a PhD in 1996 for research on Janus kinases (JAKS), Signal Transducers and Activators of Transcriptions (STATs) and signal transduction in response to the interferons and Interleukin-6[4] supervised by Ian M. Kerr.[1]

Research and career

Briscoe was a postdoctoral researcher at Columbia University with Thomas Jessell.[1] [5] In 2000 he moved to the National Institute for Medical Research to establish his own research group and in 2001 he was elected an EMBO Young Investigator.

His research interests include the molecular and cellular mechanisms of embryonic development with a particular focus on the developing spinal cord with a particular interest in how sonic hedgehog gradients and the hedgehog signaling pathway[6] regulate the development of this tissue.[7] [8] [1] To address these questions, he uses a range of experimental biology and computational biology techniques with model systems that include laboratory mouse and chick embryos as well as embryonic stem cells.[1]

Awards and honours

Briscoe was awarded the EMBO Gold Medal in 2008 and elected a member of the European Molecular Biology Organization (EMBO) in 2009.[1] In 2018 he became editor-in-chief of the journal Development.[1] [3] He was elected a Fellow of the Royal Society (FRS) in 2019 and is a Fellow of the Academy of Medical Sciences (FMedSci).

Notes and References

  1. Web site: Dr James Briscoe. https://web.archive.org/web/20190424061526/https://royalsociety.org/people/james-briscoe-14081/. 2019-04-24. royalsociety.org. Royal Society. London. Anon. 2019. One or more of the preceding sentences incorporates text from the royalsociety.org website where:
  2. Web site: James Briscoe: Developmental Dynamics Laboratory. Francis Crick Institute. crick.ac.uk. London.
  3. Brown. Katherine. An interview with James Briscoe. Development. 145. 6. 2018. dev165274. 0950-1991. 10.1242/dev.165274. 29588292. free.
  4. PhD. King's College London (University of London). JAKs, STATs and signal transduction in response to the interferons and interleukin-6. James. Briscoe. 1996. . jisc.ac.uk. 940139742.
  5. Briscoe. James. Arber. Silvia. 2019. Thomas M. Jessell (1951–2019). Development. en. 146. 10. 10.1242/dev.180505. 0950-1991. 31126924. free.
  6. Briscoe. James. Thérond. Pascal P.. The mechanisms of Hedgehog signalling and its roles in development and disease. Nature Reviews Molecular Cell Biology. 14. 7. 2013. 416–429. 1471-0072. 10.1038/nrm3598. 23719536. 25137907 .
  7. Briscoe. James. Pierani. Alessandra. Jessell. Thomas M. Ericson. Johan. A Homeodomain Protein Code Specifies Progenitor Cell Identity and Neuronal Fate in the Ventral Neural Tube. Cell. 101. 4. 2000. 435–445. 0092-8674. 10.1016/S0092-8674(00)80853-3. 10830170. free.
  8. Ericson. J. Rashbass. P. Schedl. A. Brenner-Morton. S. Kawakami. A. van Heyningen. V. Jessell. T.M. Briscoe. J. Pax6 Controls Progenitor Cell Identity and Neuronal Fate in Response to Graded Shh Signaling. Cell. 90. 1. 1997. 169–180. 0092-8674. 10.1016/S0092-8674(00)80323-2. 9230312. free.